Removal of the laryngeal mask airway in the post-anesthesia care unit : A means of process optimization?
Summary of "Removal of the laryngeal mask airway in the post-anesthesia care unit : A means of process optimization?"
Removal of the laryngeal mask airway in the post-anesthesia care unit could potentially contribute to a faster turnover from one operation to the next. The aim of this study was, therefore, to obtain an insight into the potential time saving and the safety of planned removal of the ProSeal™-LMA (PLMA) in the post-anesthesia care unit.
In this study 120 adult patients with American Society of Anesthesiologists (ASA) classification I-II, age range 18-85 years, undergoing a surgical procedure under general anesthesia in which the PLMA was used were randomly assigned to one of two groups. In group I, the PLMA was removed in the awake patient in the operating room close to the end of the procedure. In group II, the anesthetised but spontaneously breathing patients were moved to the recovery room and the PLMA removed when the patient was awake. The anesthesia technique was standardized [balanced, sevoflurane, fentanyl, bispectral index-guided (BIS) target value=35 ± 5] and identical in both groups until randomization. Patients were breathing room air during transport to the recovery room. Different time intervals as well as the incidence of critical incidents were compared between groups. An oxygen saturation (S(p)O(2)) value < 95% was considered a clinically relevant and S(p)O(2) values < 90% as clinically critical O(2)-desaturation.
Removal of the PLMA took place after an average of 4.9 ± 5.1 min in group I and after 19.5 ± 9.6 min in group II. There was no difference in the availability of the anesthetist in the operating room for the following procedure between groups (group
12 ± 5.6 min vs. group
10.7 ± 4.2 min, p > 0.05) despite the fact that patients of group II left the operating room faster (4.9 ± 3.9 min) than patients of group I (7.1 ± 5.1 min, p < 0.01). In group II patients were ready for discharge (White score=12) from the recovery room later (13.2 ± 8.2 min) than in group I (3.6 ± 4.8 min, p < 0.01). There were no significant differences in other process related time intervals between group I and group
duration of the operation (113.2 ± 45.9 min vs. 105.3 ± 42.6 min), duration of dressing (5.1 ± 3.7 min vs. 4.6 ± 2.8 min), duration of transport to the recovery room (3.9 ± 1.3 min vs. 3.6 ± 1.3 min) and information at end of surgery by the surgeon (22.5 ± 9.3 min vs. 22.4 ± 10.5 min). The incidence of clinically relevant as well as clinically critical O(2) desaturation at the time of recovery room arrival (S(p)O(2) ≤ 90%) was increased in group II with 33.3% vs. 56.6% and 13.3% vs. 6.7%, p < 0.01, respectively.
Planned PLMA removal in the recovery room after BIS-guided balanced anesthesia did not enable the anesthetist to be available earlier for induction of anesthesia in the following patient. Hence the anesthetist could not contribute to a faster turnover of cases. Obviously, with the type of close communication between surgeon and anesthetist dictated by the study protocol (announcement of expected end of surgery by the surgeon 20 min before end of surgery) it is possible for the patient to regain consciousness within a very small time window following the end of surgery. Following this kind of protocol, postponement of removal of the LMA in the recovery room does not seem to be attractive neither from a clinical nor an economic point of view. In contrast, removal of LMA in the recovery room should be restricted to occasional cases with an abrupt end of the operation or prolonged emergence from anesthesia. The obvious risk of hypoxemia necessitates continuous O(2) application and S(p)O(2) monitoring during transport to the recovery room.
Klinik für Anästhesie und Intensivtherapie, Universitätsklinikum Gießen-Marburg, Marburg, Deutschland, firstname.lastname@example.org.
This article was published in the following journal.
Name: Der Anaesthesist
- PubMed Source: http://www.ncbi.nlm.nih.gov/pubmed/21881929
- DOI: http://dx.doi.org/10.1007/s00101-011-1936-6
Quantification of the depth of desflurane anesthesia required for laryngeal mask airway (LMA) removal in children has been done with the use of intravenous fentanyl or caudal anesthesia. This study ai...
Conflicting results have been reported for the i-gel and the laryngeal mask airway proseal (LMA-P) during general anesthesia. The objective of the current investigation was to compare the efficacy and...
Laryngeal mask is a supraglothic instrument for ventilation of patients who are under anesthesia. Insertion of laryngeal mask requires maintaining sufficient depth of anesthesia to avoid airway reflex...
One day after removal of an AuraStraight disposable laryngeal mask, a plastic laryngeal mask airway cuff shield was retrieved from the oropharynx of a 5-year-old child refusing to eat, drooling, and p...
Both propofol infusions with oxygen delivered through nasal cannula and isoflurane/N2O (nitrous oxide) delivered via a laryngeal mask airway (LMA) are used to provide anesthesia for children undergoin...
The aim of the current study is to compare the use of laryngeal mask airway (LMA) and endotracheal tube (ETT) in pediatric adenotonsillectomy. The primary objective is to assess the incid...
The purpose of this study is to compare the use of a laryngeal mask airway (LMA) vs. face-mask ventilation (FMV) during first-line neonatal resuscitation in Mulago Hospital, Kampala, Ugand...
The aim of this study is to evaluate the success rate, insertion time and complication depending on the use of neuromuscular blocking agent when inserting the laryngeal mask airway (LMA).
The Air-Q® intubating laryngeal airway (Air-Q® ILA) is an extraglottic device specifically engineered for use both as a stand-alone laryngeal mask airway (LMA) and as a rescue device or ...
The intention of this study is to compare the performance of the single-use I-gel laryngeal mask with the classic laryngeal mask in 50 patients with a BMI>25 during elective surgery. Prima...
Medical and Biotech [MESH] Definitions
A type of oropharyngeal airway that provides an alternative to endotracheal intubation and standard mask anesthesia in certain patients. It is introduced into the hypopharynx to form a seal around the larynx thus permitting spontaneous or positive pressure ventilation without penetration of the larynx or esophagus. It is used in place of a facemask in routine anesthesia. The advantages over standard mask anesthesia are better airway control, minimal anesthetic gas leakage, a secure airway during patient transport to the recovery area, and minimal postoperative problems.
Cancers or tumors of the LARYNX or any of its parts: the GLOTTIS; EPIGLOTTIS; LARYNGEAL CARTILAGES; LARYNGEAL MUSCLES; and VOCAL CORDS.
A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).
Branches of the vagus (tenth cranial) nerve. The recurrent laryngeal nerves originate more caudally than the superior laryngeal nerves and follow different paths on the right and left sides. They carry efferents to all muscles of the larynx except the cricothyroid and carry sensory and autonomic fibers to the laryngeal, pharyngeal, tracheal, and cardiac regions.
The hospital unit in which patients with acute cardiac disorders receive intensive care.